help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arbogast, L. A.
Right arrow Articles by Voogt, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arbogast, L. A.
Right arrow Articles by Voogt, J. L.
Endocrinology Vol. 139, No. 6 2857-2862
Copyright © 1998 by The Endocrine Society


ARTICLES

Endogenous Opioid Peptides Contribute to Suckling-Induced Prolactin Release by Suppressing Tyrosine Hydroxylase Activity and Messenger Ribonucleic Acid Levels in Tuberoinfundibular Dopaminergic Neurons1

Lydia A. Arbogast and James L. Voogt

Department of Physiology, University of Kansas Medical Center, Kansas City, Kansas 66160-7401

Address all correspondence and requests for reprints to: Dr. Lydia A. Arbogast, Department of Physiology, School of Medicine, Southern Illinois University at Carbondale, Carbondale, Illinois 62901-6512. E-mail: larbogast{at}som.siu.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The endogenous opioid peptides have been implicated in the control of the suckling-induced PRL rise during lactation. This study examined the role of the endogenous opioid peptides in suppressing tuberoinfundibular dopaminergic neuronal activity during lactation. In the first experiment, lactating rats were constantly exposed to pups. Naloxone (NAL; 60 mg/kg·h; iv), an opioid receptor antagonist, or saline was infused for 12 h. Blood was collected before and at 2-h intervals during the infusion. NAL suppressed circulating PRL levels to less than 36% of control values at 4, 6, 8, and 12 h after the onset of the infusion. Tyrosine hydroxylase (TH) activity in the stalk-median eminence and TH messenger RNA signal levels in the arcuate nucleus were determined at the end of the NAL infusion. TH activity and TH messenger RNA signal levels were increased 2.5- and 2.7-fold, respectively, after the 12-h NAL infusion. Even though the time spent with their pups was similar between the two groups, the pups in the NAL-treated group failed to gain weight during the 12-h NAL infusion period, whereas the control litters (8 pups) gained 5 g. In a second experiment, pups were removed from the dams before the 12-h NAL infusion and were returned after 11 h. Blood was collected before the infusion, at 3-h intervals during the pup separation period, and at 15-min intervals after reunion with the pups. Plasma PRL in control and NAL-treated rats was low (1–15 ng/ml) and similar during the separation period. The suckling-induced PRL surge in NAL-treated rats was markedly attenuated to 9–25% of control levels (350–650 ng/ml). After a 1-h suckling episode, TH activity in the stalk-median eminence of NAL-treated rats was 4.5-fold greater than controls. Litter weight gains were significantly less in NAL-treated rats during the 1-h suckling episode. These data indicate that the endogenous opioid peptides are an integral component for increasing PRL release in response to suckling and they act to decrease tuberoinfundibular dopaminergic neuronal activity during lactation, in part, by suppressing TH gene expression.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THE SUCKLING stimulus from the young is the most powerful signal to increase PRL secretion in mammalian species. The control of PRL secretion during lactation involves increased input from PRL releasing factor(s) (1, 2, 3) and decreased tuberoinfundibular dopaminergic (TIDA) neuronal activity (4, 5, 6, 7, 8, 9). The effect of suckling on dopaminergic activity is illustrated most dramatically by the large increase in neuronal activity seen after separation from the pups. The changes in neuronal activity after pup removal are manifested by increased dopamine secretion in hypophysial portal blood (4), increased dihydroxyphenylalanine (DOPA) accumulation in the median eminence (7, 9), increased tyrosine hydroxylase (TH) messenger RNA (mRNA) levels in the arcuate nucleus (8, 9), and increased Fos-related antigen expression in the TIDA neurons (10). However, the complex neuronal pathways involved in translating the suckling stimulus to increased PRL secretion and the interactions between these factors and the TIDA neurons are not completely understood.

The endogenous opioid peptides have also been implicated in the suckling-induced PRL rise. The acute suckling-induced PRL rise is blocked by naloxone (NAL) (11, 12), as well as specific µ and {kappa} opioid receptor antagonists (12). Although it is not known which of the endogenous opioid peptides contribute to the suckling-induced PRL release, ß-endorphin (11, 13), as well as specific µ-selective opioid peptides (14), can acutely increase PRL release in postpartum rats. NAL (11), as well as µ, {kappa}, and {delta} (13) receptor antagonists can block ß-endorphin-induced PRL release in postpartum rats.

Although it is not clear which of the endogenous opioid systems contribute to the elevated PRL levels in response to the suckling stimulus, there is evidence that opioid gene expression in hypothalamic areas is different during lactation than other endocrine states in female rats. The POMC cellular mRNA signal levels (15) or number of POMC mRNA-containing cells (16) in the arcuate nucleus and periarcuate area were less in lactating rats than in diestrous rats. However, few of the TIDA perikarya receive contacts from ß-endorphin terminals (17, 18), although one cannot rule out interactions at the level of the median eminence. In contrast, proenkephalin mRNA levels in the arcuate nucleus were higher during lactation, compared with diestrous females (19). The induction of enkephalin immunoreactivity in the TIDA neurons during lactation (20) furnishes a way for enkephalin to act as an autocrine regulator of TIDA neurons during lactation. Prodynorphin mRNA levels in the paraventricular nucleus were also higher in lactating than in diestrous rats (21). Indeed, about 70% of the TIDA neurons have contacts with dynorphin terminals (17), and immunoneutralization of dynorphin results in increased TIDA neuronal activity in male rats (22).

It seems that the endogenous opioid peptides exert their action at the hypothalamic level to alter PRL secretion (23, 24, 25). Although a nondopaminergic mechanism(s) may also be involved in the opiate stimulation of PRL release (26, 27), a number of studies indicate that the endogenous opioid peptides interact with the TIDA neurons. The endogenous opioid peptides (28, 29, 30, 31, 32), morphine (30, 31, 33, 34) and specific agonists (35, 36) suppress TIDA neuronal activity. This opioid peptide-dopamine interaction seems to be physiologically important during the nocturnal PRL surge in pregnant rats (37). Recently, Callahan et al. (38) reported that µ-, but not {kappa}-opioid receptor antagonists increase DOPA accumulation in the median eminence of both pup-deprived and pup-suckled dams after a 4–5 h separation period. The objective of this study was to evaluate whether the opioid effect on dopaminergic neurons is physiologically important in the regulation of PRL release during lactation.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Animals
Female Sprague-Dawley rats (225–250 g) were obtained from Sasco (Omaha, NE). Rats were housed under controlled temperature (22 C) and lighting conditions (lights on 0600–1800 h) and supplied with food and water ad libitum. All procedures were approved by the Kansas University Medical Center animal care and use committee. The estrous cycles of female rats were followed by daily vaginal lavage. Each female was placed with a single male on the day of proestrus for mating purposes. Pregnant rats were housed individually after day 16 of gestation. The litter size was adjusted to eight pups per dam on postpartum day 2 (parturition day = day 1). The dams were implanted with a jugular vein cannula under ether anesthesia on day 5 of lactation and allowed to recover for 2 days before the experiments.

Exp 1: constant suckling stimulus
The lactating rats with litters were placed in the experimental cages on day 6 of lactation. An extension tubing was connected to the cannula between 0800–0900 h on day 7 of lactation to allow for blood sampling without disturbing the rats. The litters were weighed and returned to the dams. An infusion of NAL (60 mg/kg·h; iv) or heparinized saline (20 U/ml heparin; 300 µl/h; iv) was initiated at 0900 h, immediately after an initial (0 min) blood sample. The concentration of NAL was adjusted to individual body weights so that the vol of infusion was 300 µl/h. To evaluate the contribution of behavioral changes, the rats were observed at 2-h intervals and scored with a plus (lactating dam with pups in nest) or minus (dam away from pups). In addition, the attachment of pups to the nipples was noted. After observation, blood samples (350 µl) were collected from the jugular vein cannula at 2-h intervals for a 12-h period. After each sample, the extension tubing and cannula were filled with a predetermined volume of either NAL or heparinized saline to completely fill all tubing. The extension tubing was immediately reconnected to the pump so that the infusion would continue uninterrupted. The interruption of the infusion caused by sampling was less than 2 min every 2 h. For in situ hybridization studies, the rats were rapidly decapitated at 2100 h after the 12-h infusion period; the brains were collected and frozen immediately in Histofreeze 2000 (Fisher Scientific, St Louis, MO) at -70 C. In experiments to evaluate TH activity, the rats were injected with m-hydroxybenzylhydrazine dihydrochloride (NSD 1015; 25 mg free base/kg; iv), an L-aromatic amino acid decarboxylase inhibitor, after the 12-h blood sample and rapidly decapitated after an additional 15 min. The NAL/vehicle infusion was continued after the NSD 1015 injection. The stalk-median eminence (SME) was dissected with fine scissors, frozen immediately on dry ice, and stored at -20 C until analyzed for catecholamine content. In both groups, the litters were weighed at the completion of the experiment.

Exp 2: acute sucking stimulus
An extension tubing was connected to the jugular vein cannula at the start of the experiment and a 0 h blood sample collected. The pups were then removed from the dams and weighed. NAL (60 mg/kg·h; iv) or heparinized saline infusion was initiated. Blood samples were collected at 3, 6, and 9 h during the infusion period. After 11 h of infusion, the litters were weighed again and returned to the dams immediately after a 0 min blood sample was collected. Blood was collected at 15, 30, 45, and 60 min after the onset of the suckling stimulus (4 pups attached to nipples). After the 60-min blood sample, NSD 1015 (25 mg/kg; iv) was injected. The lactating rats were rapidly decapitated after 15 min, the SME dissected, and DOPA accumulation determined. The litters were weighed at the end of the 1-h suckling episode.

Determination of DOPA accumulation
The SME was homogenized in 120 µl of 0.1 N perchloric acid and centrifuged at 10,000 x g for 2 min. The content of DOPA in the SME was determined by HPLC with electrochemical detection, as described previously (39). The pellet was solubilized in 0.5 N sodium hydroxide and analyzed for protein content by the method of Bradford (40).

In situ hybridization for TH mRNA
Coronal sections (15 µM) were cut through the arcuate nucleus and thaw mounted on Superfrost Plus microscope slides (Fisher Scientific). Brain sections were fixed in 4% paraformaldehyde and subjected to an in situ hybridization procedure, as described previously (39). After prehybridization steps, the brain sections were hybridized overnight at 45 C with 2 x 106 dpm of a specific antisense 35S-labeled cRNA probe for TH with a specific activity of 5 x 108 dpm/µg. The probe was synthesized using SP6 RNA polymerase from a 1.1-kb BamHI/EcoRI insert subcloned into a pSP65 vector. After ribonuclease treatment and a series of posthybridization washes that increased in stringency, the slides were dipped in Ilford Emulsion (K-5), diluted 0.25 g/ml water. The autoradiographs were exposed for 4 weeks, developed by standard photographic methods, and poststained lightly with hematoxylin.

The anatomical locations of the tissue sections were determined using the rat brain atlas of Paxinos and Watson (41). The rostral border was -2.5 mm, and the caudal border was -3.1 mm from the bregma. Approximately 18 cells/tissue section (i.e. 300–350 cells/rat), selected from all areas of the arcuate nucleus, were analyzed. TH mRNA-containing cells were identified, under darkfield optics, as a cluster of reduced silver grains with an identifiable cell nucleus. The number of grains in individual mRNA-containing cells was measured under x 400 darkfield illumination by a computerized image-processing system (Georgia Instruments, Roswell, GA).

PRL determinations
The blood was centrifuged at 10,000 x g for 5 min, and plasma PRL levels were determined using the rat PRL RIA kit provided by NIDDK. PRL RP-3 was used as the reference preparation and [125 I]PRL (New England Nuclear, Boston, MA) as the radiolabeled antigen. The limit of sensitivity for the assay was 1 ng/ml. The intra- and interassay coefficients of variation were 12.1% and 9.1%, respectively.

Statistical analysis
Results are expressed as the mean ± SE. The n for all groups refers to the number of experimental animals. When two groups were compared, the data were analyzed by Student’s t test (42). For circulating PRL levels, the data were analyzed by ANOVA for repeated measures, and multiple comparisons were made with Fisher’s least-significant procedures (42, 43).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Effect of NAL on circulating PRL levels
In the first experiment, the lactating rats were constantly exposed to their pups for the entire 12-h experimental period, so that the suckling stimulus would be maintained for an extended period of time. Fig. 1Go shows circulating PRL concentrations at 2-h intervals in control and NAL-treated rats. An initial fall in circulating PRL levels during the first 2 h was observed in both groups, likely because of manipulations to attach the extension tubing and weighing the pups. In control rats, PRL levels were consistently elevated to approximately 200 ng/ml during 4–12 h of saline infusion. However, plasma PRL levels in the NAL-treated rats were markedly lower (P < 0.05) than control values.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 1. Circulating PRL levels in lactating rats, which were constantly exposed to pups, during saline (control) or NAL (60 mg/kg·h; iv) infusion. Plasma PRL levels in the NAL-treated rats were markedly lower than control values at 4–12 h during the infusion period. Each value is a mean ± SE of determinations from 17 (control) or 14 (NAL) rats. *, Values significantly (P < 0.05) different from the respective control values.

 
Tuberoinfundibular dopaminergic neuronal function
A 12-h period was selected for the NAL infusion, because this is the time required for near maximal increase in TH mRNA levels after pup removal (8). In pup-exposed lactating rats, TH activity in the SME was 2.5-fold greater (P < 0.05) after 12 h of NAL infusion than after saline control infusion (Fig. 2Go, left panel). Similarly, TH mRNA signal levels in the arcuate nucleus were increased (P < 0.05) 2.7-fold after 12 h of NAL infusion (Fig. 2Go, middle panel; Fig. 3Go). In contrast, TH mRNA signal levels in the medial zona incerta were similar in control and NAL-treated rats (Fig. 2Go, right panel).



View larger version (20K):
[in this window]
[in a new window]
 
Figure 2. TH activity in the SME (left panel) and TH mRNA signal levels in the arcuate nucleus (middle panel) and medial zona incerta (right panel) of pup-exposed lactating rats, after 12 h saline (control) or NAL (60 mg/kg·h; iv) infusion. TH activity in the SME and TH mRNA signal levels in the arcuate nucleus are increased after NAL infusion. Each value is a mean ± SE of determinations from eight to nine rats (TH activity) or six rats (TH mRNA levels). *, Significantly (P < 0.05) different from the respective control values.

 


View larger version (106K):
[in this window]
[in a new window]
 
Figure 3. Darkfield photomicrographs show coronal sections through the arcuate nucleus at the level of the midmedian eminence after 12-h saline (control; left panel) or NAL (60 mg/kg·h; iv; right panel) infusion. Note the presence of cell bodies in the arcuate nucleus with a dense accumulation of silver grains. The brightness of the TH mRNA-containing cells is increased after NAL infusion.

 
Litter weight changes and behavioral observations
To assess the physiological consequences of NAL treatment on the pups, the litters (eight pups/litter) were weighed before starting the 12-h infusion and after the conclusion of the infusion. Control litters gained about 5 g/8 pups during the 12 h of suckling (Fig. 4Go). In contrast, the litters from the NAL-treated rats did not gain weight during the 12-h period. For comparison, the litter weight loss associated with 12 h of separation from normal dams was determined. The separated litters lost significantly (P < 0.05) more weight (approximately 2 g/8 pups) than litters from NAL-treated dams during the 12-h period.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 4. Litter (eight pups) weight change during the 12-h period for lactating rats, which were constantly exposed to their pups, during saline (control) or NAL (60 mg/kg·h; iv) infusion. Litters from control rats gained weight during 12 h of suckling, whereas litters from NAL-treated rats did not gain weight. For comparison, the weight loss associated with 12 h of separation from normal dams is shown in the open bar. Each value is a mean ± SE of determinations from 14–17 rats. *, Significantly (P < 0.05) different from control values.

 
The percent of time the dams spent in the nest with the pups was estimated by observations at 2-h intervals during the 12-h infusion of NAL or saline. Control dams spent 73.4 ± 4.5% time, and NAL-treated dams spent 62.0 ± 7.2% time with the pups. Thus, the NAL infusion did not alter the percent time the dams spent in the nest. Pups were attached to the nipples when the dams were with the nest similarly in both groups of rats.

Acute suckling induced PRL rise and TH activity
A separate experiment evaluated the effect of NAL on the acute suckling-induced PRL rise. The pups were removed at the beginning of the experiment and returned to the dams after an 11-h separation period. At the time the pups were removed, PRL levels were high (380 ng/ml) in the two groups of rats before the onset of treatment (Fig. 5Go). Within 3 h after pup removal, PRL levels were comparably less than 2 ng/ml in both the control and NAL-treated rats and remained low and similar for the 11-h separation period. In the control rats, PRL levels were markedly elevated, to 650 ng/ml, within 15 min after the pups were returned. In sharp contrast, PRL levels were only 56 ng/ml in the NAL-treated rats after the pups were returned. The suckling-induced PRL levels remained elevated to 350–400 ng/ml for 60 min in the control rats, whereas the suckling-induced PRL rise was markedly suppressed, to less than 100 ng/ml at 15–60 min after the onset of suckling in the NAL-treated rats.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 5. Circulating PRL levels in lactating rats from which pups were removed during the initial 11 h of saline (control) or NAL (60 mg/kg·h; iv) infusion and pups were returned during the final 1 h of treatment. During the 11-h period of pup separation, circulating PRL values were similar in control and NAL-treated rats. After return of the pups, the suckling-induced PRL surge was markedly suppressed at 15–60 min after the onset of suckling. Each value is a mean ± SE of determinations from eight rats. *, Significantly (P < 0.05) different from the respective control values.

 
TH activity in the SME was evaluated in these same groups of rats after the 60-min suckling stimulus. The suckling stimulus was continued during the 15-min period of DOPA accumulation after NSD 1015 injection iv to undisturbed dams. TH activity in the SME of lactating rats was increased (P < 0.05) 4.5-fold in the NAL-treated group after a 1-h suckling episode at the end of a 12-h NAL or saline (control) infusion period (Fig. 6Go).



View larger version (21K):
[in this window]
[in a new window]
 
Figure 6. TH activity in the SME of lactating rats after a 1-h suckling episode at the end of a 12-h saline (control) or NAL (60 mg/kg·h; iv) infusion. TH activity was increased in NAL-treated rats. Each value is a mean ± SE of determinations from eight to nine rats. *, Significantly (P < 0.05) different from control values.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We are reporting that an endogenous opioid peptide(s) decreases TIDA neuronal activity during lactation and thus contributes to the elevated PRL levels essential for normal lactation. The data in this study indicate that many aspects of the TIDA neurons are attenuated by the opioidergic input, including TH gene expression at the molecular level. Conclusions of an endogenous opioid peptide(s) involvement in these processes stem from studies using NAL, an opioid receptor antagonist. Infusion of NAL caused a marked increase in TH activity in the SME and TH mRNA in the arcuate nucleus. This augmented TIDA neuronal activity was associated with suppression of both the high PRL levels associated with a constant suckling stimulus and the acute suckling-induced PRL rise after pup separation. Moreover, the NAL-induced suppression of PRL secretion had physiological consequences, in terms of reduced pup weight gain during suckling.

A decrease in TIDA neuronal activity has been clearly implicated in maintaining the high PRL levels associated with a prolonged suckling stimulus (4, 5, 6, 7, 8, 9). This study supports the inverse relationship between TIDA neuronal activity and PRL secretion in the lactating rat. Furthermore, these data endorse the notion that the endogenous opioid peptides are an essential component in maintaining elevated PRL levels by acting on the TIDA neurons. TH activity in the SME was increased after 12 h of NAL infusion. This occurred when the dams were constantly exposed to the pups and after a 1-h suckling episode in dams deprived of their pups for an 11-h period. It can be inferred from these data, that the TH activity was elevated after the 11-h separation period and that the suckling stimulus resulted in a decrease in TH activity within 60–75 min after the onset of suckling. Although the experimental designs were somewhat different, these data are in general agreement with previous reports that the suckling stimulus acutely decreases dopamine turnover and TH activity in the median eminence (5, 7).

The prolonged blockade of opioid receptors in the present study also revealed that opioidergic input affects the expression of the TH gene in the TIDA neurons. TH mRNA signal levels in the arcuate nucleus were markedly increased after the 12-h NAL infusion. In fact, it is notable that the increase in TH gene expression caused by the NAL infusion is similar to that associated with pup separation (8, 9). The 12-h duration for the NAL infusion was selected because TH mRNA content in the arcuate nucleus is not significantly increased until 6 h after separation and continues to increase between 6 and 24 h after pup removal (8). The increases in TH gene expression after pup separation (9) and NAL infusion (this study) seem to be specific to the TIDA neurons and are not observed in dopaminergic neurons in the medial zona incerta.

The data are in general agreement with those by Callahan et al. (38) that a µ-selective, but not {kappa}-selective, opioid receptor antagonist increased DOPA accumulation in the median eminence of both pup-deprived and pup-suckled dams after a 4- to 5-h separation period. The differences in timing and mode of antagonist administration [i.e. 4 h for µ-selective antagonist and 45 min for {kappa}-selective antagonist, by Callahan et al. (38), and 12-h continuous administration of NAL in the present study] make it difficult to draw conclusions about the specific receptor subtype involved in regulating TH gene expression. However, given that NAL has a high affinity for µ-opioid receptors, moderate affinity for {kappa}-opioid receptors, and relatively low affinity for {delta}-opioid receptors (44), it is likely that either µ- and/or {kappa}-type receptors may be involved in the opioidergic effects on TH activity and mRNA levels in the TIDA neurons in the constantly suckled lactating model.

The physiological consequences on the pups during the 12-h NAL infusion were remarkable. The pups of the NAL-treated dams failed to gain weight during the 12-h infusion period, whereas pups of control dams gained a significant amount of weight. However, the pups apparently did receive some milk during the NAL infusion, because complete separation from dams resulted in pup weight loss. This could not be explained by disruption of maternal behavior, because the time control and NAL-treated dams spent with the pups was similar. Observation of the pups indicated that the pups in the NAL-treated group were suckling vigorously when the dams were with the nest. Indeed, opiates disrupt maternal behavior, and NAL can prevent this disruption (45, 46). Although there is some controversy on the effect of endogenous opioid peptides on oxytocin secretion, it is unlikely that milk ejection failure caused the lack of weight gain in the present study. Hartman et al. (47) reported that NAL treatment did not alter the suckling-induced oxytocin release in conscious, normally hydrated rats, as with the dams in the present study. Reports of an opioid effect on oxytocin neurons indicate that the opioid action on oxytocinergic neurons is to restrain oxytocin release and that NAL augments oxytocin secretion (48).

The apparent escape of PRL release from the NAL-induced suppression was also somewhat striking. Although slightly variable among animals, this phenomenon seems to be synchronized at 6 h and 10 h after the initiation of NAL infusion. In a physiological sense, this may reflect the importance of lactation to sustaining mammalian species and, thus, the multiple mechanisms to maintain adequate lactation.

It is unclear whether the NAL effects on PRL secretion solely involve changes in TIDA neuronal activity. There is evidence that decreased dopaminergic activity may not completely account for opiate-induced PRL release and that PRL-releasing factor(s) may also be involved (26, 27). Indeed, one cannot rule out the possibility that the endogenous opioid peptides could alter nondopaminergic neurons, as well, and that effects on other factors could also contribute to the NAL suppression of suckling-induced PRL release. This study also does not identify which of the major opioidergic neuronal systems contribute to the control of PRL secretion during lactation. However, proenkephalin expression in the arcuate nucleus (19) and dynorphin expression in the paraventricular nucleus (21) are higher in lactating rats than in diestrous rats.

In conclusion, the endogenous opioid peptides are an integral component in the suckling-dependent elevation of PRL secretion during lactation. Moreover, the endogenous opioid peptides reduce TIDA neuronal activity in response to suckling and contribute to the marked suppression of TH gene expression during lactation. Without the opioidergic input, normal lactation seems to be severely compromised. These data support the notion that the TIDA neurons are an intermediate in the essential opioidergic enhancement of PRL secretion in response to suckling.


    Acknowledgments
 
We wish to thank the National Hormone and Pituitary Program (NIDDK, NICHHD, USDA) for the gift of PRL RIA materials.


    Footnotes
 
1 This work was supported by a Kansas University Medical Center Research Institute grant (to L.A.A.) and NIH Grant HD-24190 (to J.L.V.). Back

Received December 9, 1997.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Samson WK, Lumpkin MD, McCann SM 1986 Evidence for a physiological role for oxytocin in the control of prolactin secretion. Endocrinology 119:554–560[Abstract/Free Full Text]
  2. Murai I, Ben-Jonathan N 1987 Posterior pituitary lobectomy abolishes the suckling-induced rise in prolactin (PRL): evidence for a PRL-releasing factor in the posterior pituitary. Endocrinology 121:205–211[Abstract/Free Full Text]
  3. Samson WK, Bianchi R, Mogg RJ, Rivier J, Vale W, Melin P 1989 Oxytocin mediates the hypothalamic action of vasoactive intestinal peptide to stimulate prolactin secretion. Endocrinology 124:812–819[Abstract/Free Full Text]
  4. Ben-Jonathan N, Neill MA, Arbogast LA, Peters LL, Hoefer MT 1980 Dopamine in hypophysial portal blood: relationship to circulating prolactin in pregnant and lactating rats. Endocrinology 106:690–696[Abstract/Free Full Text]
  5. Selmanoff M, Wise PM 1981 Decreased dopamine turnover in the median eminence in response to suckling in the lactating rat. Brain Res 212:101–115[CrossRef][Medline]
  6. Plotsky PM, Neill JD 1982 The decrease in hypothalamic dopamine secretion induced by suckling: comparison of voltammetric and radioisotopic methods of measurement. Endocrinology 110:691–696[Abstract/Free Full Text]
  7. Demarest KT, McKay DW, Riegle GD, Moore KE 1983 Biochemical indices of tuberoinfundibular dopaminergic neuronal activity during lactation: a lack of response to prolactin. Neuroendocrinology 36:130–137[Medline]
  8. Wang H-J, Hoffman GE, Smith MS 1993 Suppressed tyrosine hydroxylase gene expression in the tuberoinfundibular dopaminergic system during lactation. Endocrinology 133:1657–1663[Abstract/Free Full Text]
  9. Arbogast LA, Voogt JL 1996 The responsiveness of tuberoinfundibular dopaminergic neurons to prolactin feedback is diminished between early lactation and midlactation in the rat. Endocrinology 137:47–54[Abstract]
  10. Hoffman GE, Le W-W, Abbud R, Lee W-S, Smith MS 1994 Use of Fos-related antigens (FRAs) as markers of neuronal activity: FRA changes in dopamine neurons during proestrus, pregnancy and lactation. Brain Res 654:207–215[CrossRef][Medline]
  11. Selmanoff M, Gregerson KA 1986 Suckling-induced prolactin release is suppressed by naloxone and stimulated by ß-endorphin. Neuroendocrinology 42:255–259[CrossRef][Medline]
  12. Baumann MH, Rabii J 1991 Inhibition of suckling-induced prolactin release by µ- and {kappa}-opioid antagonists. Brain Res 567:224–230[CrossRef][Medline]
  13. Kehoe L, Parman R, Janik J, Callahan P 1993 Opiate receptor subtype involvement in the stimulation of prolactin release by ß-endorphin in female rats. Neuroendocrinology 57:875–883[Medline]
  14. Baumann MH, Rabii J 1990 Mu-selective opioid peptides stimulate prolactin release in lactating rats. J Neuroendocrinol 2:271–284
  15. Smith MS 1993 Lactation alters neuropeptide-Y and proopiomelanocortin gene expression in the arcuate nucleus of the rat. Endocrinology 133:1258–1265[Abstract/Free Full Text]
  16. Mann PE, Rubin BS, Bridges RS 1997 Differential proopiomelanocortin gene expression in the medial basal hypothalamus of rats during pregnancy and lactation. Mol Brain Res 46:9–16[Medline]
  17. Fitzsimmons MD, Olschowka JA, Wiegnad SJ, Hoffman GE 1992 Interaction of opioid peptide-containing terminals with dopaminergic perikarya in the rat hypothalamus. Brain Res 581:10–18[CrossRef][Medline]
  18. Horvath TL, Naftolin F, Leranth C 1992 ß-Endorphin innervation of dopamine neurons in the rat hypothalamus: a light and electron microscopic double immunostaining study. Endocrinology 131:1547–1555[Abstract/Free Full Text]
  19. Ottinger MA, Rosewell KL, Weiland NG, Margaretten KT, Wise PM 1995 Effect of lactation on hypothalamic proenkephalin gene expression. J Neuroendocrinol 7:341–346[CrossRef][Medline]
  20. Merchenthaler I 1993 Induction of enkephalin in tuberoinfundibular dopaminergic neurons during lactation. Endocrinology 133:2645–2651[Abstract/Free Full Text]
  21. Eriksson M, Ceccatelli S, Uvnäs-Moberg K, Iadarola M, Hökfelt T 1996 Expression of fos-related antigens, oxytocin, dynorphin and galanin in the paraventricular and supraoptic nuclei of lactating rats. Neuroendocrinology 63:356–367[Medline]
  22. Manzanares J, Wagner EJ, Lookingland KJ, Moore KE 1992 Effects of immunoneutralization of dynorphin1–17 and dynorphin1–8 on the activity of central dopaminergic neurons in the male rat. Brain Res 587:301–305[CrossRef][Medline]
  23. Voogt JL, Resch G, Turkington S 1989 Arcuate nucleus and preoptic area involvement in beta-endorphin-induced release of prolactin in conscious ovariectomized rats. J Neuroendocrinol 1:449–453[CrossRef][Medline]
  24. Rivier C, Vale W, Ling N, Brown M, Guillemin R 1977 Stimulation in vivo of the secretion of prolactin and growth hormone by ß-endorphin. Endocrinology 100:238–241[Abstract/Free Full Text]
  25. Wiesner JB, Koenig JI, Krulich L, Moss RL 1984 Site of action for ß-endorphin-induced changes in plasma luteinizing hormone and prolactin in the ovariectomized rat. Life Sci 34:1463–1473[CrossRef][Medline]
  26. Arita J, Porter JC 1984 Relationship between dopamine release into hypophysial portal blood and prolactin release after morphine treatment in rats. Neuroendocrinology 38:62–67[CrossRef][Medline]
  27. Shin SH, Obonsawin MC, VanVugt DA, Baby N 1988 Morphine can stimulate prolactin release independent of a dopaminergic mechanism. Can J Physiol Pharmacol 66:1381–1385[Medline]
  28. Ferland L, Fuxe K, Eneroth P, Gustafsson J-A, Skett P 1977 Effects of methionine-enkephalin on prolactin release and catecholamine levels and turnover in the median eminence. Eur J Pharmacol 43:89–90[CrossRef][Medline]
  29. Arita J, Kimura F 1988 Enkephalin inhibits dopamine synthesis in vitro in the median emience portion of rat hypothalamic slices. Endocrinology 123:694–699[Abstract/Free Full Text]
  30. Deyo SN, Swift RM, Miller RJ 1979 Morphine and endorphins modulate dopamine turnover in rat median eminence. Proc Natl Acad Sci USA 76:3006–3009[Abstract/Free Full Text]
  31. Gudelsky GA, Porter JC 1979 Morphine- and opioid peptide-induced inhibition of the release of dopamine from tuberoinfundibular neurons. Life Sci 25:1697–1702[CrossRef][Medline]
  32. VanLoon GR, Ho D, Kim C 1980 ß-Endorphin-induced decrease in hypothalamic dopamine turnover. Endocrinology 106:76–80[Abstract/Free Full Text]
  33. Alper RH, Demarest KT, Moore KE 1980 Morphine differentially alters synthesis and turnover of dopamine in central neuronal systems. J Neural Transm 48:157–165[CrossRef]
  34. Reymond MJ, Kaur C, Porter JC 1983 An inhibitory role for morphine on the release of dopamine into hypophysial portal blood and on the synthesis of dopamine in tuberoinfundibular neurons. Brain Res 262:253–258[CrossRef][Medline]
  35. Manzanares J, Wagner EJ, LaVigne SD, Lookingland KJ, Moore KE 1992 Sexual differences in kappa opioid receptor-mediated regulation of tuberoinfundibular dopaminergic neurons. Neuroendocrinology 55:301–307[Medline]
  36. Manzanares J, Durham RA, Lookingland KJ, Moore KE 1993 {delta}-Opioid receptor-mediated regulation of central dopaminergic neurons in the rat. Eur J Pharmacol 249:107–112[CrossRef][Medline]
  37. Sagrillo CA, Voogt JL 1991 Endogenous opioids mediate the nocturnal prolactin surge in the pregnant rat. Endocrinology 129:925–930[Abstract/Free Full Text]
  38. Callahan P, Baumann MH, Rabii J 1996 Inhibition of tuberoinfundibular dopaminergic neural activity during suckling: involvement of µ and {kappa} opiate receptor subtypes. J Neuroendocrinol 8:771–776[CrossRef][Medline]
  39. Arbogast LA, Voogt JL 1991 Hyperprolactinemia increases and hypoprolactinemia decreases tyrosine hydroxylase messenger ribonucleic acid levels in the arcuate nuclei, but not the substantia nigra or zona incerta. Endocrinology 128:997–1005[Abstract/Free Full Text]
  40. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254[CrossRef][Medline]
  41. Paxinos G, Watson C 1986 The Rat Brain in Stereotaxic Coordinates. Academic Press, New York
  42. Zar JH 1984 Biostatistical Analysis. Prentice-Hall, ed. 2, Englewood Cliffs, NJ
  43. Gerald KB 1990 Common multiple comparison procedures. Nurse Anesthesia 1:162–165[Medline]
  44. Minami M, Satoh M 1995 Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci Res 23:121–145[CrossRef][Medline]
  45. Bridges RS, Grimm CT 1982 Reversal of morphine disruption of maternal behavior by concurrent treatment with the opiate antagonist naloxone. Science 218:166–168[Abstract/Free Full Text]
  46. Mann PE, Kinsley CH, Bridges RS 1991 Opioid receptor subtype involvement in maternal behavior in lactating rats. Neuroendocrinology 53:487–492[Medline]
  47. Hartman RD, Rosella-Dampman LM, Summy-Long JY 1987 Endogenous opioid peptides inhibit oxytocin release in the lactating rat after dehydration and urethane. Endocrinology 121:536–543[Abstract/Free Full Text]
  48. Russell JA, Coombes JE, Leng G, Bicknell RJ 1993 Morphine tolerance and inhibition of oxytocin secretion by {kappa}-opioids acting on the rat neurohypophysis. J Physiol 469:365–386[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
J EndocrinolHome page
C. Deachapunya, S. Poonyachoti, and N. Krishnamra
Regulation of electrolyte transport across cultured endometrial epithelial cells by prolactin
J. Endocrinol., June 1, 2008; 197(3): 575 - 582.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
N. Thongon, L.-i. Nakkrasae, J. Thongbunchoo, N. Krishnamra, and N. Charoenphandhu
Prolactin stimulates transepithelial calcium transport and modulates paracellular permselectivity in Caco-2 monolayer: mediation by PKC and ROCK pathways
Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1158 - C1168.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
W. Jantarajit, N. Thongon, J. Pandaranandaka, J. Teerapornpuntakit, N. Krishnamra, and N. Charoenphandhu
Prolactin-stimulated transepithelial calcium transport in duodenum and Caco-2 monolayer are mediated by the phosphoinositide 3-kinase pathway
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E372 - E384.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. Ben-Jonathan and R. Hnasko
Dopamine as a Prolactin (PRL) Inhibitor
Endocr. Rev., December 1, 2001; 22(6): 724 - 763.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Z. B. Andrews, I. C. Kokay, and D. R. Grattan
Dissociation of Prolactin Secretion from Tuberoinfundibular Dopamine Activity in Late Pregnant Rats
Endocrinology, June 1, 2001; 142(6): 2719 - 2724.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy
Prolactin: Structure, Function, and Regulation of Secretion
Physiol Rev, October 1, 2000; 80(4): 1523 - 1631.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arbogast, L. A.
Right arrow Articles by Voogt, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arbogast, L. A.
Right arrow Articles by Voogt, J. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals